Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study

Mamta Parikh, Chong-Xian Pan, Laurel A Beckett, Yueju Li, Daniel A. Robles, Pawandeep K. Aujla, Primo N Lara

Research output: Contribution to journalArticle

2 Scopus citations

Fingerprint Dive into the research topics of 'Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study'. Together they form a unique fingerprint.

Medicine & Life Sciences